At Cincinnati Children’s, we make science count for kids.
Every day, more than 1,000 doctors, nurses, scientists, researchers and staff in our Cancer and Blood Diseases Institute work as focused teams to provide the most innovative care for the most difficult cancer cases in the world.
Our ongoing success in using the latest research to support the best care for children with cancer helps explain why our cancer program was ranked No. 5 in the 2017-18 list of Best Children’s Hospitals published by U.S. News & World Report.
“We have the nation’s leading pediatric cancer experts with outstanding international reputations, but the key ingredient is team science,” says John Perentesis, MD, FAAP, director of oncology and cancer programs and co-director of the Cancer and Blood Diseases Institute. “Each of our clinical teams is embedded with basic science researchers. This close collaboration allows advances from the laboratory to reach children as quickly as possible.”
We also invest in the latest technology to make cancer treatment safer and more effective for children and young adults. Our $120 million Proton Therapy and Research Center is already transforming how children receive radiation therapy. Looking ahead, our team is working in the nation’s only dedicated particle therapy research unit to develop new innovations in cancer care.
“We have the largest array of new anti-cancer treatments for children of any medical center in the country. As a result, children with very complex cases are referred here from all around the world,” Perentesis says.
Why We Stand Out
- Our precision genomics-guided treatment program receives referrals from all around the world to help children with high-risk or relapsed malignancies. Our research shows that about 50 percent of children with high-risk cancers experience tumor shrinkage after genomics-guided treatment compared to just 6 percent without genomic guidance.
We are the leading national center for bone marrow transplants and a leader in developing anti-cancer immune therapies, including a new program that uses engineered T-cells against relapsed leukemias.
We have developed an innovative, multidisciplinary fertility preservation program that will help girls and boys undergoing cancer treatment become parents when they grow up.
Scientists in our Brain Tumor Center continue to develop a potential breakthrough method to convert deadly high-grade gliomas into a much more treatable type of tumor. If early success continues, this approach may provide much-improved outcomes for children with rare, difficult-to-treat tumors.
Learn more about our Cancer and Blood Diseases Institute.